Obesity prevalence and time trend among youngsters in China, 1982-2002

Yanping Li1, Evert G Schouten, Xiaoqi Hu

  • 1National Institute for Nutrition and Food Safety, Chinese Center for Disease Control and Prevention, Beijing, China.

Insights

Overweight and obesity prevalence in Chinese children increased significantly from 1982 to 2002, nearing epidemic levels. Concurrently, stunting among overweight and obese youth saw a dramatic decrease.

Area of Science:

  • Pediatric Nutrition
  • Public Health Trends
  • Childhood Obesity Epidemiology

Background:

  • Childhood overweight and obesity are growing global health concerns.
  • Understanding trends in China is crucial due to its large child population.
  • The co-existence of undernutrition (stunting) and overnutrition (overweight/obesity) presents a complex public health challenge.

Purpose of the Study:

  • To analyze the prevalence and trends of overweight and obesity in Chinese children and adolescents aged 7-17 years from 1982 to 2002.
  • To investigate the co-existence of overweight/obesity with stunting during the same period.
  • To provide data for public health interventions and policy-making in China.

Main Methods:

  • Utilized data from three national cross-sectional surveys conducted in 1982, 1992, and 2002.
  • Included a large sample of children (7-17 years) across the survey years.
  • Defined overweight and obesity using International Obesity Task Force (IOTF) BMI cut-offs and stunting as height-for-age below -2 SD from NCHS/WHO reference.

Main Results:

  • Overweight prevalence rose from 1.2% (1982) to 4.4% (2002); obesity prevalence increased from 0.2% (1982) to 0.9% (2002).
  • Increases in overweight and obesity were more pronounced in urban boys.
  • The proportion of overweight/obese children who were also stunted significantly decreased from 28.4% (1982) to 5.7% (2002).

Conclusions:

  • Childhood overweight and obesity in China have shown a rapid increasing trend since 1982.
  • If current trends persist, overweight and obesity may reach epidemic proportions.
  • A notable decline in stunting among overweight and obese children occurred simultaneously with the rise in overnutrition.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...